香港股市 已收市

Johnson & Johnson (JNJ)

NYSE - NYSE 延遲價格。貨幣為 USD。
加入追蹤清單
147.91+2.17 (+1.49%)
收市:04:00PM EDT
147.71 -0.20 (-0.14%)
收市後: 07:59PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價145.74
開市146.15
買盤145.72 x 1000
賣出價145.70 x 800
今日波幅144.54 - 148.13
52 週波幅143.13 - 175.97
成交量9,579,927
平均成交量7,489,601
市值356.431B
Beta 值 (5 年,每月)0.53
市盈率 (最近 12 個月)19.91
每股盈利 (最近 12 個月)7.43
業績公佈日2024年7月17日
遠期股息及收益率4.96 (3.40%)
除息日2024年5月20日
1 年預測目標價174.21
  • Benzinga

    Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert

    The World Health Organization (WHO) is poised to issue a broader alert regarding contaminated children’s cough syrup produced by Johnson and Johnson (NYSE:JNJ) in response to the discovery of tainted batches in Nigeria. Last week, Nigeria’s regulatory body recalled a specific batch of Benylin syrup after detecting elevated levels of diethylene glycol during routine testing. This compound, along with a related toxin, has been implicated in the deaths of over 300 children across several countries

  • Insider Monkey

    12 Best Diversified Stocks To Invest In

    In this article, we will take a look at the 12 best diversified stocks to invest in. To know more about the top stocks, go directly to 5 Best Diversified Stocks To Invest In. Forbes asked a group of experts about the changing global landscape and its effect on investors. These experts included Justin Onuekwusi (JO), […]

  • Reuters

    UPDATE 2-WHO likely to issue wider alert on contaminated J&J cough syrup

    The World Health Organization is likely to issue a wider warning about contaminated Johnson and Johnson-made children's cough syrup found in Nigeria last week, it said in an email. Nigeria's regulator recalled a batch of Benylin paediatric syrup last Wednesday, having found a high level of diethylene glycol in the product during routine testing. The contaminant, alongside another closely related toxin, ethylene glycol, has been linked to the deaths of more than 300 children in Cameroon, Gambia, Indonesia and Uzbekistan since 2022, though there is no evidence that these incidents are linked with the latest recalls.